372 related articles for article (PubMed ID: 26100857)
21. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
22. Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.
Li J; Inoue J; Choi JM; Nakamura S; Yan Z; Fushinobu S; Kamada H; Kato H; Hashidume T; Shimizu M; Sato R
J Biol Chem; 2015 Sep; 290(39):24021-35. PubMed ID: 26272613
[TBL] [Abstract][Full Text] [Related]
23. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
24. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
Simão AL; Afonso MB; Rodrigues PM; Gama-Carvalho M; Machado MV; Cortez-Pinto H; Rodrigues CMP; Castro RE
J Mol Med (Berl); 2019 Aug; 97(8):1113-1126. PubMed ID: 31139863
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
Chen L; Yu S; Hong S; Lin X; Zhu X; Cao X; Li Y; Xiao H
Drug Dev Res; 2023 Apr; 84(2):156-171. PubMed ID: 36541217
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
27. Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α.
Ren H; Hu F; Wang D; Kang X; Feng X; Zhang L; Zhou B; Liu S; Yuan G
Hepatology; 2021 Aug; 74(2):723-740. PubMed ID: 33636024
[TBL] [Abstract][Full Text] [Related]
28. MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPARα pathway in HepG2 cells.
Wen F; An C; Wu X; Yang Y; Xu J; Liu Y; Wang C; Nie L; Fang H; Yang Z
Int J Biochem Cell Biol; 2018 Jan; 94():133-145. PubMed ID: 29197627
[TBL] [Abstract][Full Text] [Related]
29. 18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism.
Yang M; Zhang M; Liu Q; Xu T; Huang T; Yao D; Wong CW; Liu J; Guan M
Pharmacol Res; 2020 Jul; 157():104840. PubMed ID: 32353589
[TBL] [Abstract][Full Text] [Related]
30. Ablation of carotenoid cleavage enzymes (BCO1 and BCO2) induced hepatic steatosis by altering the farnesoid X receptor/miR-34a/sirtuin 1 pathway.
Lim JY; Liu C; Hu KQ; Smith DE; Wang XD
Arch Biochem Biophys; 2018 Sep; 654():1-9. PubMed ID: 30006135
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
34. Positive regulation of hepatic miR-122 expression by HNF4α.
Li ZY; Xi Y; Zhu WN; Zeng C; Zhang ZQ; Guo ZC; Hao DL; Liu G; Feng L; Chen HZ; Chen F; Lv X; Liu DP; Liang CC
J Hepatol; 2011 Sep; 55(3):602-611. PubMed ID: 21241755
[TBL] [Abstract][Full Text] [Related]
35. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
36. An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function.
Morimoto A; Kannari M; Tsuchida Y; Sasaki S; Saito C; Matsuta T; Maeda T; Akiyama M; Nakamura T; Sakaguchi M; Nameki N; Gonzalez FJ; Inoue Y
J Biol Chem; 2017 Jun; 292(25):10574-10585. PubMed ID: 28465351
[TBL] [Abstract][Full Text] [Related]
37. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
[TBL] [Abstract][Full Text] [Related]
38. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
